Navigation Links
WebMD Announces Fourth Quarter Financial Results
Date:2/18/2010

2010 Financial Guidance  

The Company issued financial guidance for 2010 today.

“We enter 2010 with a healthy backlog of signed contracts as we experienced strong upfront buying at the end of 2009,” said Wayne Gattinella. “Coupled with our strong pipeline of potential new business, we are very enthusiastic about the year ahead.”

For 2010, WebMD expects:

  • Revenue to be approximately $510 million to $525 million, an increase of 16% to 20% over 2009;
  • Adjusted EBITDA to be approximately $150 million to $158 million, an increase of 33% to 40% over 2009; and
  • Income from continuing operations to be approximately $45 million to $53 million, or $0.68 to $0.80 per diluted share.  

These amounts represent growth of approximately 21% to 25% in public portal advertising and sponsorship revenue over 2009 and private portal services revenue consistent with 2009.

For the first quarter of 2010, WebMD expects:

  • Revenue to be in the range of $103 million to $106 million with Adjusted EBITDA representing approximately 21.5% to 22.5% of revenue.
  • Income from continuing operations is estimated to be in the range of 2% to 3.5% of revenue.

Additional detail is provided in a schedule attached to this release.

Analyst and Investor Conference Call

As previously announced, WebMD will hold a conference call with investors and analysts to discuss its fourth quarter results at 4:45 p.m. (Eastern) today. The call can be accessed at

SOURCE WebMD
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

Related medicine news :

1. WebMD Launches New Version of Free Mobile Application for Physicians
2. WebMD to Present at the 12th Annual Needham Growth Stock Conference
3. WebMD Health Corp. Announces Preliminary Results of Its Tender Offer
4. WebMD Announces Third Quarter Financial Results
5. FDA and WebMD Expand Consumer Health Information Partnership
6. WebMD to Present at the Canaccord Adams 29th Annual Global Growth Conference
7. WebMD Announces Second Quarter Financial Results
8. WebMD Launches Free Mobile Application For Physicians
9. HLTH and WebMD Announce Second Quarter Earnings Release Date and Conference Call
10. HLTH Corporation and WebMD Health Corp. Announce Agreement to Merge
11. WebMD to Present at Jefferies 3rd Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... fractional flow reserve (FFR) using pressure wire assessment ... leads to significant changes in the management of ... a study reported at EuroPCR 2013. , The ... strategy at coronary angiography for diagnosis of chest ... assessment of FFR in all the main coronary ...
(Date:5/24/2013)... discovery at Oregon Health & Science University highlights an ... infected with the highly evasive HIV virus that causes ... this unique approach to develop its own HIV vaccine ... animal studies. This latest research finding will be published ... Science . , "A major challenge in ...
(Date:5/24/2013)... CBT News.com recently announced the addition of ... retail automotive industry news organization with 12 years experience in ... join a group that’s so forward-thinking in their approach,” says ... video content is on the rise.” , Atlanta born and ... segued into advertising at Cycle News and Boating World. He ...
(Date:5/24/2013)... American International College of Arts and ... agreement with Old Dominion University (ODU) that ... , The program will permit ODU students ... cell biology course, taught by AICASA’s faculty, for three ... of Antigua (AUA) College of Medicine , students will ...
(Date:5/24/2013)... recommended well-child visits had up to twice the risk ... their visits, according to a study published today in ... study included more than 20,000 children enrolled at Group ... asthma and heart disease were even more likely to ... study. In fact, children with chronic conditions who ...
Breaking Medicine News(10 mins):Health News:Diagnostic coronary angiography: Functional flow reserve changes decisions in 25 percent of cases 2Health News:OHSU research highlights promising strategy to help vaccines outsmart HIV 2Health News:AICASA Signs Articulation Agreement with Old Dominion University to Create Study Abroad Program 2Health News:Young children who miss well-child visits are more likely to be hospitalized 2Health News:Young children who miss well-child visits are more likely to be hospitalized 3
... Brand Innovation is offering a custom e-book, "Notes on Nursing" by Florence ... e-book is one in a series of e-books titled I ... C la s s i ... http://www.stinsonbrandinnovation.com/ebooks/SBI_NotesOnNursing.htm , "This is a way we celebrate the vital ...
... survey also finds unique mix of bacteria for each person ... "atlas" of bacterial life on and within the human body ... are a veritable United Nations of germs. , The scientists, ... they like to thrive on and within the body. They ...
... Picture it: One jerk in a bar spends the night ... the evening, the women aren,t receptive to even the nicest ... evolutionary theory. Males increase their fitness by acquiring more mates; ... and therein lies the conflict. Researchers at Binghamton University ...
... mimic parents, language, study finds , THURSDAY, Nov. 5 ... days old cry with intonation patterns that reflect the ... The conclusion drawn by German researchers is that fetuses ... trimester of pregnancy, laying the groundwork for learning language ...
... Seats still ... ... economy recovers from the recession, the province’s health care sector is just one industry taking ... the field and an increased need for nursing care from the province’s aging population. Anyone ...
... House Rules Committee announced that the "rule" for ... put forward by Rep. Brad Ellsworth, D-Ind. that the House ... language, House Democratic leaders hope to address the reluctance of ... , Dr. Charmaine Yoest, President and CEO of ...
Cached Medicine News:Health News:National Nurse Practitioner Week Recognized by STINSON Brand Innovation With Offer of 'Notes on Nursing' e-book 2Health News:Germs Mingle Most on Palms, Feet, Forearms 2Health News:Germs Mingle Most on Palms, Feet, Forearms 3Health News:Mom was right: Nice guys don't always finish last 2Health News:Fetus Learns Intonations of Mother's Tongue 2Health News:Fetus Learns Intonations of Mother's Tongue 3Health News:Practical Nursing Still a Growth Area in BC 2
(Date:5/24/2013)... , May 24, 2013  An international roster of ... May 18, in Santa Monica, Calif. ... lung-sparing therapies for MPM, a rare form of cancer ... the pleura, the lining of the chest. ... Blood Institute, the 3rd Annual International Symposium on Lung-Sparing ...
(Date:5/24/2013)... 2013 China Biologic Products, Inc. (Nasdaq: CBPO, ... plasma-based biopharmaceutical company in China , ... a public announcement issued by Shanghai RAAS Blood Products ... Shenzhen Stock Exchange, that on May 21, 2013, Ms. ... one of the shareholders of the Company, and her ...
(Date:5/24/2013)... 2013 In accordance with Rule 17.1 and Rule ... the United States Exchange Act, Echo Pharma Acquisition Limited ("Royalty ... Corporation (NYSE: ELN). Background On 2 ... offer for the entire of the issued and to be ... Offer").  On 20 May 2013, Royalty Pharma ...
Breaking Medicine Technology:International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 2International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 9
... division of Wyeth (NYSE: WYE ), presented ... showed that bazedoxifene/conjugated,estrogens reduced the number and severity ... to 80 percent, when compared with placebo. These,data, ... Meeting,also showed that bazedoxifene/conjugated estrogens improved symptoms of,vulvar ...
... study published in the Oct. 1,Journal of Nutrition suggests ... the risk of prostate cancer, Solae notes, giving consumers ... The study, "Soy protein isolate increases urinary estrogens ... risk of prostate cancer,",is believed to be the first ...
Cached Medicine Technology:Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens 2Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens 3Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens 4Study Suggests Soy Protein May Reduce Prostate Cancer Risk 2
... Detection Of Serum C-Peptide ... Measurement:, Evaluating patients ... Assisting in the classification ... Differentiating insulin dependent patients ...
Inquire...
The Pach IV is the premier product for cornea thickness measurement in conjunction with Glaucoma screening....
Inquire...
Medicine Products: